Fairvalue-Calculator Fairvalue-Calculator
EN DE

ezCaretech Co (099750) Fair Value & Analysis

Healthcare · KR · Market cap 102B KRW

Price6,270 KRW
Fair Value2,352 KRW
Upside-62.5%
Quality95/100
Evidence: High Range 1,764 KRW – 2,940 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

ezCaretech Co (099750) currently trades at 6,270 KRW, while our model-based Fair Value estimate is 2,352 KRW — implying the stock looks roughly 62.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

ezCaretech Co., LTD engages in the provision of various modules for hospital operations in South Korea, Saudi Arabia, the United States, Japan, and internationally. The company's solutions include BESTCare 2.0, an EMR/EHR solution that optimizes workflows, enhances patient safety and empowerment, minimizes workload for healthcare professionals, and ensures data sharing. It also offers Behavioral specialized HER, a solution for behavioral health; and Cloud HER, which provides a standardized system, security, and software maintenance. The company is headquartered in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is ezCaretech Co (099750) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 2,352 KRW versus a price of 6,270 KRW — about −62% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 099750?
Our 21-model fair value for ezCaretech Co is 2,352 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 6,270 KRW.
What is the quality score of 099750?
ezCaretech Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.